Herbal Capsule and Dosage-Form Contract Manufacturing from India: What International Brands Need to Know

Most international wellness brands sourcing from India are sourcing raw ingredients: herbal powders, botanical extracts, essential oils. The supply chain is well-documented, the trade flows are established, and the regulatory pathway is relatively clear for buyers who invest in supplier qualification.

A smaller but growing segment of international brands is asking a different question: can we source finished products from India? Not raw ashwagandha extract to formulate ourselves, but finished ashwagandha capsules, ready for labelling and retail. Not bulk turmeric powder, but turmeric-curcumin softgels in blister packs. Not moringa powder for a co-packer, but moringa powder in sachets, produced to specification by an Indian contract manufacturer.

Our article on sourcing private label ayurvedic products from India goes further.

This is a fundamentally different supply chain question. The ingredients are the same; the product type, the regulatory framework, and the sourcing process are not.

This guide covers what international brands need to know about outsourcing finished herbal dosage-form production to Indian contract manufacturers: what the Indian contract manufacturing landscape looks like, how the regulatory framework differs from raw ingredient export, what certifications to require, what MOQs to expect, and what the import documentation looks like at the destination end.

Why This Question Is Emerging Now

India has a well-established pharmaceutical contract manufacturing industry, and the country’s herbal and Ayurvedic sector sits alongside it - often in the same industrial parks, using similar GMP-compliant manufacturing infrastructure.

Several factors are driving increased international interest in finished herbal dosage-form sourcing from India.

Cost structure. Indian contract manufacturing for herbal capsules and tablets operates at significantly lower cost than equivalent production in the EU, USA, UK, or Australia - reflecting lower labour costs, proximity to raw material supply, and competitive market pricing among a large base of qualified manufacturers.

Vertical integration. For brands already sourcing raw Indian herbal ingredients, contracting finished dosage-form production in India eliminates one or more supply chain steps, reducing logistics complexity and cost.

AYUSH export growth. India’s Ministry of AYUSH has positioned the export of Ayurvedic and herbal finished products as a priority sector, with government support for WHO-GMP certification upgrades among Indian Ayurvedic manufacturers.

Post-pandemic capacity availability. Significant pharmaceutical and nutraceutical manufacturing capacity became available following the pandemic-era production surge, creating competitive pricing from facilities that would previously not have accepted small international orders.

The Critical Distinction: Raw Ingredients vs. Finished Dosage Forms

The most important thing to understand before approaching an Indian contract manufacturer is that finished herbal dosage forms are a different product category from raw herbal ingredients - in regulatory terms, in HS code classification, and in the documentation requirements at both the Indian export end and the destination import end.

Raw herbal ingredients (HS 1211, 1302): Botanicals in raw, dried, or extract form. Classified as food ingredients or botanical ingredients in most markets. Subject to food safety import regulations, phytosanitary inspection, and - in some markets - botanical novel food assessment. Standard documentation: Certificate of Analysis, phytosanitary certificate, Certificate of Origin, GMP certificate.

Bulk herbal formulations (HS 3003): Mixed herbal constituents in bulk form, not measured into individual doses. An intermediate category used in some Ayurvedic export scenarios.

Finished dosage forms (HS 3004): Herbal products in measured dosage form - capsules, tablets, softgels, sachets. Classified in most markets as health supplements, dietary supplements, or medicines, depending on the health claims made. Import regulations are significantly more complex: they may require product registration, pharmacovigilance compliance, label pre-approval, or import health certification depending on the market. Documentation requirements are substantially more extensive.

Buyers who have experience importing raw Indian herbal ingredients and assume finished capsule imports follow the same pathway often encounter customs holds, documentation insufficiency notices, or product registration requirements they were not expecting. Confirming the destination-market regulatory pathway before placing a contract manufacturing order is not optional - it is the critical first step.

The Indian Regulatory Framework for Herbal Finished Product Export

Understanding how Indian regulatory authorities classify herbal finished products is essential for sourcing the right manufacturer with the right documentation.

AYUSH vs. FSSAI: The Classification Question

The central regulatory question for any Indian herbal finished product is whether it is classified as an Ayurvedic drug or as a food supplement.

AYUSH pathway: Products classified as Ayurvedic medicines or drugs are regulated under the Drugs and Cosmetics Act 1940, administered by State Drug Controllers under the Ministry of AYUSH. The manufacturer must hold an AYUSH Manufacturing Licence issued by their State Drug Controller. Export of Ayurvedic drug-classified products requires a Free Sale Certificate from the State Drug Controller or CDSCO confirming the product is approved for sale in India.

FSSAI pathway: Products positioned as health supplements, nutraceuticals, or functional foods fall under the Food Safety and Standards Act 2006 and are regulated by FSSAI. The manufacturer must hold a valid FSSAI manufacturing licence. The product must comply with FSSAI Health Supplements Regulations 2016, which specify permitted ingredients, maximum levels, and labelling requirements.

The classification is not always straightforward. A product containing ashwagandha extract in capsule form could legitimately be classified as an Ayurvedic medicine (under AYUSH) or a dietary supplement (under FSSAI), depending on the claims made and the intended market. The classification determines which manufacturing licence the facility holds, which documentation accompanies the export, and how the product will be classified at the destination country’s port of entry.

For international buyers, the practical implication is: before selecting an Indian contract manufacturer, confirm whether the facility holds an AYUSH Manufacturing Licence, an FSSAI licence, or both - and confirm that the applicable licence matches the regulatory category under which your product will be imported in your destination market.

WHO-GMP Certification

WHO-GMP certification - issued to pharmaceutical and Ayurvedic manufacturers by their State Drug Controller, confirming compliance with World Health Organization Good Manufacturing Practice guidelines - is the international standard by which Indian herbal finished product manufacturers are assessed by foreign buyers and regulators.

A WHO-GMP certificate from a credible Indian herbal capsule manufacturer confirms:

The facility follows documented GMP procedures for cleaning, batch recording, in-process testing, and finished product release
Raw material and finished product testing is conducted by accredited internal or third-party laboratories
Environmental controls (temperature, humidity, contamination prevention) meet pharmaceutical-grade standards
Traceability exists from raw material receipt to finished product dispatch

For buyers supplying the EU, UK, Japan, or the USA, WHO-GMP certification is a baseline requirement, not a differentiator. Facilities without it should be disqualified early in the selection process.

For EU-bound finished herbal products where pharmaceutical claims are made, an EU-GMP audit or compliance letter from an EU competent authority may additionally be required.

The Indian Contract Manufacturing Landscape

India’s herbal and Ayurvedic contract manufacturing sector is concentrated in several key industrial hubs.

Uttarakhand (Haridwar and Dehradun area): The largest concentration of AYUSH-licensed Ayurvedic manufacturers in India, driven by proximity to Himalayan botanical supply chains and government support for the Ayurvedic industry. Many facilities here hold both AYUSH Manufacturing Licences and WHO-GMP certificates.

Himachal Pradesh (Baddi and Nalagarh): A major pharmaceutical and nutraceutical manufacturing hub with significant herbal dosage-form capacity. Strong WHO-GMP infrastructure with experience supplying international markets.

Gujarat (Ahmedabad and Ankleshwar): Pharmaceutical-grade manufacturing with herbal and nutraceutical crossover capacity. Strong export documentation capability.

Rajasthan: Growing Ayurvedic manufacturing base with competitive pricing and proximity to desert botanical supply chains (senna, isabgol, ashwagandha).

The quality range within this landscape is wide. At one end: well-capitalised, internationally audited facilities with modern automated capsule filling lines, accredited in-house laboratories, and experienced export documentation teams who routinely supply EU, US, and Japan buyers. At the other end: small-scale AYUSH-licensed operations with limited quality infrastructure, basic manual production, and documentation capability that does not meet the standard required for most international markets.

Identifying which type of manufacturer you are dealing with from a distance, without a site visit or a qualified local introduction, is one of the core challenges of herbal dosage-form sourcing from India.

Minimum Order Quantities: What to Expect

Finished dosage-form production involves setup costs - batch record preparation, equipment changeover and cleaning, line qualification - that do not scale linearly with volume. This means MOQs for finished products are substantially higher than for raw ingredients.

Herbal capsules (HPMC or gelatin): Most established Indian third-party manufacturers set MOQs of 50,000 to 100,000 capsules per SKU per production run. This reflects the minimum batch size for a GMP-compliant production record. Some specialty manufacturers targeting the premium international market accept runs of 25,000 capsules for high-value products, typically at a premium unit price.

Tablets (plain or film-coated): Tablet production involves additional tooling and compression setup, resulting in higher MOQs than capsules. Typical minimums range from 100,000 to 200,000 tablets per SKU. Film-coated tablets require coating line setup that further increases the minimum viable batch size.

Softgels: Softgel encapsulation requires specialised equipment and carries the highest MOQs among common herbal dosage forms - typically 100,000 to 500,000 units depending on fill weight and capsule size. Not all Indian herbal manufacturers have softgel capability; this is a more concentrated segment.

Sachets (powder-in-sachet): MOQs are typically set by total powder weight rather than unit count. Most facilities require a minimum of 500 kg to 1,000 kg of finished powder per sachet run, which translates to roughly 5,000 to 20,000 sachets depending on sachet fill weight.

For buyers whose projected volume is below these minimums, options include: consolidating multiple SKUs with the same manufacturer to reach a viable order value, sourcing through a specialist India sourcing partner who aggregates demand, or accepting a higher unit price in exchange for a lower minimum at a facility that serves small-batch premium customers.

What to Specify to an Indian Contract Manufacturer

Unlike raw ingredient sourcing, finished dosage-form outsourcing requires the buyer to define not just the ingredient but the entire product specification. A complete brief to an Indian contract manufacturer should include:

Formulation specification: Ingredient identities and quantities per dose, form (capsule, tablet, sachet), capsule shell material (HPMC for vegetarian or vegan positioning, gelatin for standard), fill weight per capsule or tablet weight.

Certification requirements: Organic (NPOP, EU Organic, or USDA NOP), halal, kosher, WHO-GMP, FSSAI, AYUSH. Confirm which certifications apply to both the product and the facility.

Packaging specification: Capsules per bottle or blister, bottle or blister type, label requirements including regulatory labelling for the destination market, secondary packaging.

Testing requirements: In-process and finished product testing parameters, heavy metal limits, pesticide residue limits, microbial limits appropriate for the destination market.

Regulatory classification: Communicate how the product will be classified in the destination country and what documentation the import requires. Indian manufacturers experienced in international export will adapt their documentation accordingly; less experienced facilities may not know what EU or US import regulations require without specific guidance.

Documentation for Finished Dosage-Form Export from India

A finished herbal capsule shipment from India requires substantially more documentation than a raw ingredient shipment. Buyers should expect and require:

Standard commercial documents: Commercial Invoice (citing HS code 3004, botanical names of all ingredients, batch number), Packing List, Bill of Lading or Airway Bill, Certificate of Origin.

Regulatory documents from the Indian end: WHO-GMP Certificate from the manufacturing facility, AYUSH Manufacturing Licence (for Ayurvedic drug-classified products), Free Sale Certificate from the State Drug Controller or CDSCO, FSSAI licence copy (for food supplement-classified products).

Quality documents: Certificate of Analysis covering identity, active constituent content, heavy metals, microbiological limits, pesticide residues, and - for Ayurvedic products - compliance with pharmacopoeial specifications where applicable.

Destination-market-specific requirements: The EU may require additional pesticide MRL analysis to EU standards and aflatoxin testing. Japan may require Japanese-language certificates and compliance documentation under JHFA or FOSHU frameworks. The USA may require FDA Prior Notice filing before arrival; NDI notification may be required for novel ingredients. The UK requires phytosanitary certificates and botanical species verification for plant-based health products under BTOM import conditions. See our guide to UK BTOM import requirements for herbal ingredients for detail on the current UK framework.

Raw Ingredient vs. Finished Product Sourcing: Which Is Right for Your Business?

The decision between sourcing raw ingredients and outsourcing finished dosage-form production is not a simple cost comparison. Both models have legitimate roles in an international brand’s supply chain.

A related question is covered in direct import versus a sourcing agent or trading company.

Source raw ingredients when you have a co-packer or in-house production capability in your market, you need flexibility to reformulate or adjust specifications without renegotiating a contract manufacturing agreement, your regulatory environment requires the product to be manufactured in a domestically licensed facility, or your volumes are below Indian contract manufacturing minimums.

Source finished dosage forms from India when you do not have or do not want a domestic co-packing relationship, the cost differential of Indian contract manufacturing is sufficient to offset the additional import complexity, your product specification is stable and your regulatory pathway in the destination market is confirmed, and you have the supplier qualification capability to select and audit an appropriate Indian facility.

For most international brands new to Indian sourcing, starting with raw ingredient import and building familiarity with Indian supplier relationships before moving to finished dosage-form outsourcing is the lower-risk progression. The documentation complexity, regulatory nuance, and facility qualification requirements for finished product sourcing are substantially higher - and the consequences of selecting the wrong facility are more severe.

Frequently Asked Questions

What is the difference between importing raw herbal ingredients from India and importing finished herbal capsules?

Raw herbal ingredients - botanicals, powders, and extracts - are classified under HS codes 1211 and 1302 and enter the buyer’s country as manufacturing inputs subject to food ingredient or botanical import regulations. Finished herbal capsules and tablets are classified under HS code 3004 and face a more complex import pathway in most markets: they may require product registration, labelling compliance review, or pharmaceutical import authorisation depending on the destination country and the health claims made. The regulatory and documentation burden for finished dosage-form imports is substantially higher than for raw ingredient imports, and buyers should confirm their destination country’s requirements before placing a contract manufacturing order.

Which regulatory authority oversees finished Ayurvedic capsule manufacturing for export in India?

The applicable Indian regulatory authority depends on how the product is classified. Products classified as Ayurvedic drugs require a manufacturing licence under the Drugs and Cosmetics Act 1940, overseen by the State Drug Controller under the AYUSH Ministry. Products positioned as health supplements or nutraceuticals fall under FSSAI regulations. Most finished herbal capsules intended for export as Ayurvedic medicines follow the AYUSH licensing pathway, requiring an AYUSH Manufacturing Licence and a Free Sale Certificate from the State Drug Controller or CDSCO as part of the export documentation package.

What certifications should a WHO-GMP Indian contract manufacturer hold for herbal capsule production?

A reliable Indian contract manufacturer for herbal capsule production should hold WHO-GMP certification from their State Drug Controller, confirming their manufacturing facility meets World Health Organization Good Manufacturing Practice standards. For EU-bound products, an additional EU-GMP certificate or audit acceptance letter may be required. Organic-certified capsule products require the contract manufacturer to also hold NPOP organic processing certification. For AYUSH-classified products, an AYUSH Manufacturing Licence is required in addition to GMP certification.

What are typical minimum order quantities for herbal capsule contract manufacturing in India?

Minimum order quantities for herbal capsule contract manufacturing in India typically range from 50,000 to 100,000 capsules per SKU for most established third-party manufacturers, reflecting the setup and batch record costs of pharmaceutical-grade production runs. Some specialist facilities accept runs of 25,000 capsules for premium-priced products. Tablet production typically carries higher MOQs than capsules, commonly 100,000 to 200,000 tablets per SKU. Herbal powder sachet runs are typically set by weight rather than unit count, with minimums ranging from 500 kg to 1,000 kg of finished powder.

What documentation does a finished herbal capsule shipment from India require at import?

A finished herbal capsule shipment from India typically requires a Commercial Invoice with HS code 3004, Packing List, Bill of Lading or Airway Bill, Certificate of Origin, Certificate of Analysis from an accredited laboratory, WHO-GMP Certificate from the manufacturing facility, AYUSH Manufacturing Licence copy for Ayurvedic drug-classified products, and a Free Sale Certificate from the State Drug Controller or CDSCO. For EU-bound shipments, additional pesticide residue and heavy metal analysis reports from an accredited laboratory are also required. The destination country may require product registration, import health certificate, or labelling pre-approval before clearance.

Ayris Global connects international buyers across the EU, UK, USA, UAE, Japan, South Korea, Australia, Southeast Asia, and Latin America with verified Indian producers of botanical extracts, herbal powders, Ayurvedic ingredients, and finished herbal products. For buyers exploring finished dosage-form sourcing from India, we can advise on regulatory pathways, introduce qualified contract manufacturers, and manage the qualification and documentation process. Visit our For Buyers page or contact our team to discuss your requirements.